AzTrials
AzTrials

Distal Radius FracturesNCT01144208

The Influence of Local Bone Status on Complications After Surgical Treatment of Distal Radius Fractures

An observational study of Distal Radius Fractures and Poor Bone Quality, run by AO Clinical Investigation and Publishing Documentation at 11 sites in 6 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate if poor bone quality increases the risk of specific types of treatment complications in patients with distal radius fractures treated with open reduction and Locking Compression Plates(LCP). Read more about this study

Who is it for?
Ages 50 to 90 years
How many people
244 participants
Where
11 sitesin 6 countries
Study dates
Feb 2007to Apr 2010
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: participating clinics will identify all eligible patients who meet the inclusion and exclusion

Who may be able to join

  • Radiologically confirmed closed fracture (within 7 days) of the distal radius
  • Primary fracture treatment with a volar LCP 2.4 mm
  • Age equal greater 50 and equal younger 90 years
  • Willing and able to give written informed consent to participate in the study
  • Willing and able to participate in the study follow-ups according to the CIP
  • Willing and able to comply with the post-operative management program
  • Able to understand and read country national language at an elementary level

Who cannot join

  • Fracture of ulna (except an associated fracture of the ulnar styloid process)
  • Open distal radius fracture
  • Concomitant contralateral radius fracture
  • Previous distal radius fracture on either side after the age of 25 years
  • Time to operation > 7 days
  • Polytrauma
Show all 14Show fewer
  • Regular systemic therapy with corticosteroids due to chronic disease
  • Legal incompetence
  • Patient received radio- or chemotherapy prior to, during, or within the last year
  • Currently active cancer
  • Recent history of substance abuse (i.e recreational drugs, alcohol)
  • Prisoner
  • Currently involved in a pharmaceutical study
  • Has a disease process that would preclude accurate evaluation (e.g. neuromuscular or rheumatic disease, significant psychiatric or metabolic disorders)

Trial locations and contacts

11 sites in 6 countries.

11 sites in 6 countries

Switzerland4 sites
  • Universitätsspital Basel

    Basel, Basel, 4031

  • Kantonsspital

    Lucerne, Canton of Lucerne, 6000

  • Kantonsspital Winterthur

    Winterthur, Canton of Zurich, 8401

  • Stadtspital Triemli

    Zurich, Canton of Zurich, 8063

Other trials in Switzerland

Germany3 sites
  • Campus Virchow-Klinikum, Charité

    Berlin, State of Berlin, 13353

  • Ev. Diakoniewerk Friederikenstift

    Hanover, Lower Saxony, 30169

  • Klinikum rechts der Isar der TU Muenchen

    Munich, Bavaria, 81675

Other trials in Germany

United States1 site
  • Massachusetts General Hospital

    Boston, Massachusetts, 02114

Other trials in United States

Austria1 site
  • Universitätsklinik für Unfallchirurgie

    Graz, Styria, 8036

Other trials in Austria

Italy1 site
  • C.T.O. Azienda Ospedaliera Careggi

    Florence, Tuscany, 50139

Other trials in Italy

Singapore1 site
  • Singapore General Hospital

    Singapore, Singapore, 169608

Other trials in Singapore

About this study

The purpose of this study is to evaluate if poor bone quality increases the risk of specific types of treatment complications in patients with distal radius fractures treated with open reduction and Locking Compression Plates(LCP).

Read the detailed description

Despite fractures of the wrist being widely regarded as "fragility fractures", there is good evidence that they are caused by diminished Bone Mineral Density (BMD) and that a low BMD value predicts a higher fracture risk at the distal radius. Both measurements of areal BMD with DXA and volumetric BMD with peripheral Quantitative Computer Tomography (pQCT)showed a lower BMD in women with Colles' fractures. Thus, Colles' fractures can be recognized as a good indication of underlying osteoporosis. High resolution peripheral Quantitative Computer Tomography at the distal radius will be evaluated in a subset of patients.

Clinical experts are concerned that osteoporosis increases the risk for poor outcomes and complication rates in surgical patients with osteoporosis. However, this has not yet been confirmed in clinical studies. It is important to investigate this question in order to correctly advise clinicians and patients and possibly develop tailored approaches for treatment of osteoporotic patients with distal radius fractures.

Keywords
Radius fracture, Adverse effects, Wrist, Postoperative complications, Colles' fracture, Intraoperative complications, Osteoporosis, Dual-energy x-ray absorptiometry (DXA), Bone Density
Medical subject headings
Wrist Fractures, Radius Fractures, Postoperative Complications, Colles' Fracture, Intraoperative Complications, Osteoporosis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Local bone quality-related complication

    The qualifying events are those involving either directly the local bone and fracture or the implant and its surgical application whether they are anticipated or not.

    Measured: From enrollment to 12 months postoperative

Secondary outcomes (26)
  1. Bone mineral density at contralateral distal radius by DXA

    Local bone status will comprise BMD and BMC of the contralateral side. The absolute values for BMD and BMC will be provided as well as the deviations to the T-score according to the manufacturer's reference collective.

    Measured: until 6 weeks postoperative

  2. Occurence of any complication

    To capture any complication that occured. A complication is defined as any occurrence or deviation from the normal treatment or outcome, regardless of whether it has any relationship with the treatment or product under investigation.

    Measured: Baseline

  3. Occurence of any complication

    To capture any complication that occured. A complication is defined as any occurrence or deviation from the normal treatment or outcome, regardless of whether it has any relationship with the treatment or product under investigation.

    Measured: 6 weeks

  4. Occurence of any complication

    To capture any complication that occured. A complication is defined as any occurrence or deviation from the normal treatment or outcome, regardless of whether it has any relationship with the treatment or product under investigation.

    Measured: 3 months

  5. Occurence of any complication

    To capture any complication that occured. A complication is defined as any occurrence or deviation from the normal treatment or outcome, regardless of whether it has any relationship with the treatment or product under investigation.

    Measured: 12 months

  6. Range of motion

    The bilateral range of motion will be measured by clinical examination as follows:

    • Dorsal extension / palmar flexion
    • Wrist ulnar abduction / radial abduction
    • Forearm supination / pronation

    Measured: 6 weeks

  7. Range of motion

    The bilateral range of motion will be measured by clinical examination as follows:

    • Dorsal extension / palmar flexion
    • Wrist ulnar abduction / radial abduction
    • Forearm supination / pronation

    Measured: 3 months

  8. Range of motion

    The bilateral range of motion will be measured by clinical examination as follows:

    • Dorsal extension / palmar flexion
    • Wrist ulnar abduction / radial abduction
    • Forearm supination / pronation

    Measured: 12 months

  9. Grip strength

    For the grip strength, the average value of three successive measurements with a Jamar dynamometer will be calculated as percentage of the contralateral, healthy side.

    Measured: 6 weeks

  10. Grip strength

    For the grip strength, the average value of three successive measurements with a Jamar dynamometer will be calculated as percentage of the contralateral, healthy side.

    Measured: 3 months

  11. Grip strength

    For the grip strength, the average value of three successive measurements with a Jamar dynamometer will be calculated as percentage of the contralateral, healthy side.

    Measured: 12 months

  12. Patient self-assessment of wrist function questionnaire (PRWE)

    PRWE was developed to rate wrist-related pain and disability in functional activities. This provides a score from 0-100, where higher scores indicate greater pain and disability.

    Measured: Baseline

  13. Patient self-assessment of hand function with the PRWE

    PRWE was developed to rate wrist-related pain and disability in functional activities. This provides a score from 0-100, where higher scores indicate greater pain and disability.

    Measured: 6 weeks

  14. Patient self-assessment of hand function with the PRWE

    PRWE was developed to rate wrist-related pain and disability in functional activities. This provides a score from 0-100, where higher scores indicate greater pain and disability.

    Measured: 3 months

  15. Patient self-assessment of hand function with the PRWE

    PRWE was developed to rate wrist-related pain and disability in functional activities. This provides a score from 0-100, where higher scores indicate greater pain and disability.

    Measured: 6 months

  16. Patient self-assessment of hand function with the PRWE

    PRWE was developed to rate wrist-related pain and disability in functional activities. This provides a score from 0-100, where higher scores indicate greater pain and disability.

    Measured: 12 months

  17. Disabilities of the arm, shoulder and hand questionnaire (DASH)

    The disability of the arm, shoulder and hand (DASH) questionnaire is an upper extremity specific outcome measure. The main part of the DASH is a 30-item disability/symptom scale concerning the patient's health status during the preceding week. The scores for all items are then used to calculate a scale score ranging from 0 (no disability) to 100 (most severe disability).

    Measured: Baseline

  18. Disabilities of the arm, shoulder and hand questionnaire (DASH)

    The disability of the arm, shoulder and hand (DASH) questionnaire is an upper extremity specific outcome measure. The main part of the DASH is a 30-item disability/symptom scale concerning the patient's health status during the preceding week. The scores for all items are then used to calculate a scale score ranging from 0 (no disability) to 100 (most severe disability).

    Measured: 6 weeks

  19. Disabilities of the arm, shoulder and hand questionnaire (DASH)

    The disability of the arm, shoulder and hand (DASH) questionnaire is an upper extremity specific outcome measure. The main part of the DASH is a 30-item disability/symptom scale concerning the patient's health status during the preceding week. The scores for all items are then used to calculate a scale score ranging from 0 (no disability) to 100 (most severe disability).

    Measured: 3 months

  20. Disabilities of the arm, shoulder and hand questionnaire (DASH)

    The disability of the arm, shoulder and hand (DASH) questionnaire is an upper extremity specific outcome measure. The main part of the DASH is a 30-item disability/symptom scale concerning the patient's health status during the preceding week. The scores for all items are then used to calculate a scale score ranging from 0 (no disability) to 100 (most severe disability).

    Measured: 12 months

  21. Health-related quality of life (EQ-5D)

    EQ-5D is a standardised instrument for use as a measure of health outcome.It has five items with a three-point categorical response scale (no problems, some/moderate problems, extreme problems. A unique EQ-5D health state is defined by combining 1 level from each of the 5 dimensions.

    Measured: Baseline

  22. Health-related quality of life (EQ-5D)

    EQ-5D is a standardised instrument for use as a measure of health outcome.It has five items with a three-point categorical response scale (no problems, some/moderate problems, extreme problems. A unique EQ-5D health state is defined by combining 1 level from each of the 5 dimensions.

    Measured: 6 weeks

  23. Health-related quality of life (EQ-5D)

    EQ-5D is a standardised instrument for use as a measure of health outcome.It has five items with a three-point categorical response scale (no problems, some/moderate problems, extreme problems. A unique EQ-5D health state is defined by combining 1 level from each of the 5 dimensions.

    Measured: 3 months

  24. Health-related quality of life (EQ-5D)

    EQ-5D is a standardised instrument for use as a measure of health outcome.It has five items with a three-point categorical response scale (no problems, some/moderate problems, extreme problems. A unique EQ-5D health state is defined by combining 1 level from each of the 5 dimensions.

    Measured: 6 months

  25. Health-related quality of life (EQ-5D)

    EQ-5D is a standardised instrument for use as a measure of health outcome.It has five items with a three-point categorical response scale (no problems, some/moderate problems, extreme problems. A unique EQ-5D health state is defined by combining 1 level from each of the 5 dimensions.

    Measured: 12 months

  26. High resolution pQCT of contralateral distal radius

    High-resolution pQCT of the contralateral side with an XTremeCT will be performed in a subset of patients in Zürich. To obtain the bone mineral content the CT values will be calibrated with the help of a phantom in hydoxyapatite (HA) densities in mg HA/cm3. The relation of bone volume to tissue volume will be calculated as BV/TV. These values will be analyzed separately.

    Measured: within 6 weeks after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jun 2010 (estimated)
  2. Study startFeb 2007
  3. Primary completionApr 2010
  4. Study completionApr 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
244 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01144208
Sponsor's protocol ID
FFOB-Rad
Status last verified
Jun 2010
First submitted
14 Jun 2010
Last updated
16 Jun 2010
Results posted
No
Data monitoring committee
No

Publications

  • Goldhahn S, Kralinger F, Rikli D, Marent M, Goldhahn J. Does osteoporosis increase complication risk in surgical fracture treatment? A protocol combining new endpoints for two prospective multicentre open cohort studies. BMC Musculoskelet Disord. 2010 Nov 9;11:256. doi: 10.1186/1471-2474-11-256.

    PubMed 21062463

Questions about this trial

What is this clinical trial studying?

An observational study of Distal Radius Fractures and Poor Bone Quality, run by AO Clinical Investigation and Publishing Documentation at 11 sites in 6 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Jun 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 11 sites in Switzerland, Germany, United States, Austria, Italy and 1 more country. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Local bone quality-related complication (time frame: From enrollment to 12 months postoperative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01144208, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2010.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in